Cart summary

You have no items in your shopping cart.

Protoescigenin 21-tiglate

SKU: orb2663494

Description

Protoescigenin 21-tiglate (compound 10), a type of Bayberry Triterpenoid Saponin (BAT), can be isolated from the acidic hydrolyzed products (AHP) of a crude extract derived from bayberry seeds. BATs are generally known for their robust anti-tumor, anti-inflammatory, and anti-Alzheimer's activities. However, the anti-tumor activity of Protoescigenin 21-tiglate is relatively weak, with inhibitory concentrations (IC50) exceeding 80 μM for MCF-7 and at 80 μM for HeLa cells.

Images & Validation

Key Properties

CAS Number7047-43-0
MW588.82
FormulaC35H56O7
SMILESC(O)[C@]12[C@](C=3[C@@](C)(C[C@H]1O)[C@@]4(C)[C@](CC3)([C@]5(C)[C@@](CC4)([C@](CO)(C)[C@@H](O)CC5)[H])[H])(CC(C)(C)[C@@H](OC(/C(=C/C)/C)=O)[C@@H]2O)[H]

Storage & Handling

Storage-20°C
DisclaimerFor research use only

Similar Products

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Protoescigenin 21-tiglate (orb2663494)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%